| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
caspase 9 | 0.458 | 0.808 | 7.4E-06 |
|
phenotype | 0.500 | None | 1.000 | 2 | 0 | 2002 | 2018 | ||||||||
|
BLK proto-oncogene, Src family tyrosine kinase | 0.585 | 0.769 | 8.3E-14 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
S100 calcium binding protein B | 0.383 | 0.923 | 4.4E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2011 | 2011 | ||||||||
|
selectin P | 0.460 | 0.769 | 5.0E-32 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2002 | 2011 | ||||||||
|
BCL2 like 1 | 0.493 | 0.885 | 0.94 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
C-C motif chemokine ligand 2 | 0.321 | 0.962 | 0.61 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2000 | 2002 | ||||||||
|
secreted frizzled related protein 2 | 0.544 | 0.731 | 1.7E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
C-X-C motif chemokine ligand 6 | 0.582 | 0.692 | 2.7E-09 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2001 | 2001 | ||||||||
|
RELA proto-oncogene, NF-kB subunit | 0.406 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
opioid receptor delta 1 | 0.604 | 0.731 | 3.3E-03 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2002 | 2002 | ||||||||
|
oxytocin/neurophysin I prepropeptide | 0.615 | 0.423 | 0.71 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2009 | 2009 | ||||||||
|
serpin family E member 1 | 0.359 | 0.885 | 4.4E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2016 | 2016 | ||||||||
|
pro-apoptotic WT1 regulator | 0.542 | 0.846 | 9.0E-02 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2008 | 2008 | ||||||||
|
platelet and endothelial cell adhesion molecule 1 | 0.426 | 0.846 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1996 | 1996 | |||||||||
|
phospholipase C delta 1 | 0.636 | 0.577 | 1.7E-19 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2003 | 2003 | ||||||||
|
phospholipase D2 | 0.617 | 0.654 | 4.1E-27 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
phospholamban | 0.595 | 0.577 | 0.45 |
|
phenotype | 0.500 | None | 1.000 | 1 | 0 | 2000 | 2011 | ||||||||
|
peroxisome proliferator activated receptor delta | 0.513 | 0.846 | 0.99 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
protein kinase C beta | 0.453 | 0.885 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2005 | 2005 | ||||||||
|
ras homolog family member A | 0.502 | 0.808 | 0.60 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
protein kinase C delta | 0.480 | 0.846 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
prostaglandin E receptor 3 | 0.601 | 0.731 | 0.37 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2007 | 2007 | ||||||||
|
RAP1A, member of RAS oncogene family | 0.502 | 0.808 | 0.62 |
|
phenotype | 0.200 | None | 1.000 | 1 | 0 | 2010 | 2010 | ||||||||
|
oxidized low density lipoprotein receptor 1 | 0.544 | 0.769 | 7.2E-03 |
|
phenotype | 0.210 | None | 1.000 | 1 | 0 | 2002 | 2002 |